{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:17:21Z","timestamp":1756462641791},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.leukres.2009.02.013","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T04:52:38Z","timestamp":1237265558000},"page":"883-885","source":"Crossref","is-referenced-by-count":4,"title":["New insights into the role of the tuberous sclerosis genes in leukemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Margit","family":"Rosner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Valli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hengstschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.02.013_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.leukres.2009.02.013_bib2","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","article-title":"Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease","volume":"24","author":"Astrinidis","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2009.02.013_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","article-title":"The mTOR pathway and its role in human genetic diseases","volume":"659","author":"Rosner","year":"2008","journal-title":"Rev Mutat Res"},{"key":"10.1016\/j.leukres.2009.02.013_bib4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"The TSC1 Consortium","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2009.02.013_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.02.013_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","article-title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting proteins","volume":"658","author":"Rosner","year":"2008","journal-title":"Rev Mutat Res"},{"key":"10.1016\/j.leukres.2009.02.013_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/cr.2007.64","article-title":"Expanding mTOR signalling","volume":"17","author":"Yang","year":"2007","journal-title":"Cell Res"},{"key":"10.1016\/j.leukres.2009.02.013_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.molmed.2007.08.001","article-title":"Targeting the mTOR signalling network in cancer","volume":"13","author":"Chiang","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.leukres.2009.02.013_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","article-title":"mTOR complex 1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer","volume":"13","author":"Dann","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.leukres.2009.02.013_bib12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","article-title":"IKK\u03b2 suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by ERK: implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib14","doi-asserted-by":"crossref","first-page":"13489","DOI":"10.1073\/pnas.0405659101","article-title":"Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase","volume":"101","author":"Roux","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2009.02.013_bib15","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1101\/gad.1199104","article-title":"Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz\u2013Jeghers syndrome","volume":"18","author":"Corradetti","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2009.02.013_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signalling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib19","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.95.26.15653","article-title":"Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2","volume":"95","author":"Soucek","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2009.02.013_bib20","doi-asserted-by":"crossref","first-page":"48707","DOI":"10.1074\/jbc.M405528200","article-title":"Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2","volume":"279","author":"Rosner","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2009.02.013_bib21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/hmg\/ddm103","article-title":"p27KIP1 localization depends on the tumor suppressor protein tuberin","volume":"16","author":"Rosner","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.leukres.2009.02.013_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2004.06.020","article-title":"Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes","volume":"6","author":"Brugarolas","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2009.02.013_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2009.02.013_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bst0310597","article-title":"Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours","volume":"31","author":"Knowles","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.leukres.2009.02.013_bib25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","article-title":"Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes","volume":"41","author":"Jiang","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2009.02.013_bib26","first-page":"7652","article-title":"Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder","volume":"63","author":"Knowles","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.02.013_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.ju.0000074621.74361.10","article-title":"Human bladder tumors with 2-hit mutations of the tumor suppressor gene TSC1 and decreased expression of p27","volume":"170","author":"Adachi","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.leukres.2009.02.013_bib28","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/hmg\/ddn098","article-title":"Bladder tumor derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms","volume":"17","author":"Pymar","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.leukres.2009.02.013_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.surg.2005.06.028","article-title":"Expression and prognostic value of tuberous sclerosis complex 2 gene product in human pancreatic cancer","volume":"138","author":"Kataoka","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.leukres.2009.02.013_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.410420215","article-title":"Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas","volume":"2","author":"Wienecke","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.leukres.2009.02.013_bib31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/sj.onc.1209851","article-title":"Frequent loss of chromosome 9, homozygous CDKN2A\/p14\/CDKN2B deletion and low TSC1 mRNA expression in pleiomorphic xanthoastrocytomas","volume":"26","author":"Weber","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2009.02.013_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-8-163","article-title":"Involvement of TSC genes and differential expression of other members of the mTOR signalling pathway in oral squamous cell carcinoma","volume":"8","author":"Chakraborty","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.leukres.2009.02.013_bib33","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/1078-0432.CCR-07-0321","article-title":"Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signalling in endometrial cancer","volume":"14","author":"Lu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2009.02.013_bib34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2009.01.041","article-title":"Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia","volume":"33","author":"Xu","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.02.013_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMe068263","article-title":"Renal-cell carcinoma\u2014molecular pathway and therapies","volume":"356","author":"Brugarolas","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.02.013_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.02.013_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T21:29:47Z","timestamp":1545341387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0145212609000939"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.02.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}